The development of additional methods for detecting and identifying Ba
besia and Plasmodium infections may be useful in disease monitoring, m
anagement and control efforts. To preliminarily evaluate synthetic pep
tide-based serodiagnosis, a hydrophilic sequence (DDESEFDKEK) was sele
cted from the published BabR gene of B. bovis. Immunization of rabbits
and cattle with the hemocyanin-conjugated peptide elicited antibody r
esponses that specifically defected both P. falciparum and B. bovis an
tigens by immunofluorescence and Western blots. Using a dot-ELISA with
this peptide, antisera from immunized and naturally-infected cattle,
and immunized rodents, were specifically detected. Reactivity was weak
and correlated with peptide immunization or infection. DNA-based dete
ction using repetitive DNA was species-specific in dot-blot formats fo
r B. bovis DNA, and in both dot-blot and in situ formals for P. falcip
arum; a streamlined enzyme-linked synthetic DNA assay for P. falciparu
m detected 30 parasites/mm3 from patient blood using either colorimetr
ic (2-15 h color development) or chemiluminescent detection (0.5-6-min
exposures). Serodiagnostic and DNA hybridization methods may be compl
ementary in the respective detection of both chronic and acute infecti
ons. However, recent improvements in the polymerase chain reaction (PC
R) make feasible a more sensitive and uniform approach to the diagnosi
s of these and other infectious disease complexes, with appropriate pr
imers and processing methods. An analysis of ribosomal DNA genes of Pl
asmodium and Toxoplasma identified Apicomplexa-conserved sequence regi
ons. Specific and distinctive PCR profiles were obtained for primers s
panning the internal transcribed spacer locus for each of several Plas
modium and Babesia species.